دورية أكاديمية

Prevalence and Severity of COVID-19 among Pediatric Patients with Atopy: A Cross-sectional Study in Kerman, Southeast Iran.

التفاصيل البيبلوغرافية
العنوان: Prevalence and Severity of COVID-19 among Pediatric Patients with Atopy: A Cross-sectional Study in Kerman, Southeast Iran.
المؤلفون: Shafiee F; Afzalipour Research Development Unit, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran. fakhry.3570@gmail.com., Sarafinejad A; Clinical Informatics Research and Development Lab, Clinical Research Development Unit, Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran. asarafinejad@kmu.ac.ir., Bazargan Harandi N; Department of Pediatrics, School of Medicine Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran. nasrin.bazargan@gmail.com., Hossininasab A; Department of Pediatrics, School of Medicine Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran. ali4221@gmail.com., Ebrahimi SS; Department of Pediatrics, School of Medicine Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran. sareh.ebrahimi913@gmail.com.
المصدر: Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2024 Apr 07; Vol. 23 (2), pp. 127-138. Date of Electronic Publication: 2024 Apr 07.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Tehran University of Medical Sciences Country of Publication: Iran NLM ID: 101146178 Publication Model: Electronic Cited Medium: Internet ISSN: 1735-5249 (Electronic) Linking ISSN: 17351502 NLM ISO Abbreviation: Iran J Allergy Asthma Immunol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2007- : Tehran : Tehran University of Medical Sciences
Original Publication: Tehran, I.R. Iran : Iranian Society of Asthma and Allergy (ISAA) and the Iranian Society of Immunology and Allergy (ISIA), [2000-2006]
مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/immunology , Severity of Illness Index* , SARS-CoV-2*, Humans ; Iran/epidemiology ; Female ; Male ; Cross-Sectional Studies ; Child ; Prevalence ; Child, Preschool ; Adolescent ; Asthma/epidemiology ; Rhinitis, Allergic/epidemiology ; Food Hypersensitivity/epidemiology
مستخلص: The tragic COVID-19 pandemic affected many children worldwide. Among the factors that may influence the course of viral infections including COVID-19, it is still uncertain whether atopy has a protective or predisposing role. The study aims to address the knowledge gap by investigating the prevalence and severity of COVID-19 among atopic children in Kerman, in 2022. A descriptive-analytical cross-sectional study on children with a history of atopy was performed in Kerman Medical University. Demographic information, type of atopy (including allergic rhinitis, Hyper-Reactive Airway Disease (HRAD) or asthma, eczema, urticaria, anaphylaxis, and food allergy), history of COVID-19 infection, and disease severity were recorded. A total of 1007 children and adolescents, (boys: 56.4%, girls: 43.6%, age:5.61±2.64 years) were included in the study. History of COVID-19 infection was positive in 53.5%, with 75.9% of the cases exhibiting mild disease severity. The frequency of atopies was HRAD or asthma (67.2%), allergic rhinitis (42.6%), and food allergy (27.4%). The frequency of COVID-19 cases was significantly higher among patients with HRAD or asthma, whereas it was significantly lower among those with food allergies, anaphylaxis, and eczema. Among atopic individuals, COVID-19 severity was significantly lower in those with allergic rhinitis, while the opposite trend was observed among food-allergic individuals. This study sheds light on the relationship between atopy and COVID-19 among pediatric patients. It seems specific types of atopies may influence the risk and severity of COVID-19 infection differently. A better understanding of these associations can inform clinical management and preventive measures for vulnerable pediatric populations.
فهرسة مساهمة: Keywords: Allergy and immunology; COVID-19; Clinical decision making
تواريخ الأحداث: Date Created: 20240601 Date Completed: 20240601 Latest Revision: 20240601
رمز التحديث: 20240602
DOI: 10.18502/ijaai.v23i2.15317
PMID: 38822508
قاعدة البيانات: MEDLINE
الوصف
تدمد:1735-5249
DOI:10.18502/ijaai.v23i2.15317